HK inno.N Corporation (195940) Stock Overview

HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers drugs for the treatment of GERD, EE, NERD, GU and H.Pylori; hypertension and dyslipidemia; diabetes with dyslipidemia; blood pressure; bacterial infections, such as pneumonia, skin infections, or blood infections; anti-cancer; antidepressants; urology; and renal disease, intravenous nutrition, and infusion, as well as provides antibiotics. It also provides active pharmaceutical ingredients, and drinks and health functional foods. The company also exports its products to Japan, Southeast Asia, Central and South America, Europe, and Vietnam. HK inno.N Corporation was founded in 1984 and is headquartered in Seoul, South Korea.